Dolph Houben

113 Neoangiogenensis, transplant viability and molecular analysis of bone VCA 5 17. Boyce, B.F. and L. Xing, Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther, 2007. 9 (Suppl 1): p. S1. doi: 10.1186/ar2165. 18. Chim, S.M., A. Qin, J. Tickner, et al., EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase. J Biol Chem., 2011. 286 (25): p. 22035-46. doi: 10.1074/jbc.M110.187633. Epub 2011 Apr 29. 19. Bieber, E.J. and M.B. Wood, Bone reconstruction. Clin Plast Surg, 1986. 13 (4): p. 645-55. 20. Kuo, Y.R., C.C. Chen, Y.C. Chen, et al., Recipient Adipose-Derived Stem Cells Enhance Recipient Cell Engraftment and Prolong Allotransplant Survival in a Miniature Swine Hind-Limb Model. Cell Transplant., 2017. 26 (8): p. 1418-1427. doi: 10.1177/0963689717724534. 21. Ohno, T., M. Pelzer, M. Larsen, et al., Host-derived angiogenesis maintains bone blood flow after withdrawal of immunosuppression. Microsurgery, 2007. 27 (8): p. 657-63. 22. Pelzer, M., M. Larsen, Y.-G. Chung, et al., Short-term immunosuppression and surgical neoangiogenesis with host vessels maintains long-term viability of vascularized bone allografts. Journal of Orthopaedic Research, 2007. 25 (3): p. 370-7. 23. Zhang, C., Y. Li, R. Cornelia, et al., Regulation of VEGF expression by HIF-1alpha in the femoral head cartilage following ischemia osteonecrosis. Sci Rep, 2012. 2:650. (doi): p. 10.1038/srep00650. Epub 2012 Sep 11. 24. Boyle, W.J., W.S. Simonet, and D.L. Lacey, Osteoclast differentiation and activation. Nature., 2003. 423 (6937): p. 337-42. doi: 10.1038/nature01658. 25. Giessler, G.A., M. Zobitz, P.F. Friedrich, et al., Transplantation of a vascularized rabbit femoral diaphyseal segment: mechanical and histologic properties of a new living bone transplantation model. Microsurgery, 2008. 28 (4): p. 291-9.